PROCEPT BioRobotics Corporation (PRCT) Gross Margin
- Gross margin · 12 months: Value 64.22%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 64.22% | Gross profit / revenue. Period ending 2026-06-30. $216.65M ÷ $337.34M × 100 ≈ 64.22% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 216.65M USD | Gross Profit |
| Revenue | 337.34M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $216.65M | $337.34M | (m) | 64.22% |
| 2026-03-31 | $206.01M | $322.02M | (m) | 63.97% |
| 2025-12-31 | $196.23M | $308.05M | (m) | 63.70% |
| 2025-09-30 | $193.59M | $299.91M | (m) | 64.55% |
| 2025-06-30 | $176.49M | $274.95M | (m) | 64.19% |
| 2025-03-31 | $156.23M | $249.12M | (m) | 62.71% |
| 2024-12-31 | $137.10M | $224.50M | (m) | 61.07% |
| 2024-09-30 | $114.68M | $199.84M | (m) | 57.39% |
| 2024-06-30 | $96.64M | $176.57M | (m) | 54.73% |
| 2024-03-31 | $83.59M | $156.33M | (m) | 53.47% |
| 2023-12-31 | $71.05M | $136.19M | (m) | 52.17% |
| 2023-09-30 | $60.47M | $116.39M | (m) | 51.96% |
| 2023-06-30 | $51.83M | $101.63M | (m) | 50.99% |
| 2023-03-31 | $41.88M | $85.22M | (m) | 49.15% |
| 2022-12-31 | $37.09M | $75.01M | (m) | 49.44% |
| 2022-09-30 | $30.93M | $61.38M | (m) | 50.39% |
| 2022-06-30 | $24.93M | $49.69M | (m) | 50.17% |
| 2022-03-31 | $20.03M | $41.48M | (m) | 48.29% |
| 2021-12-31 | $15.87M | $34.47M | (m) | 46.02% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $-1.25M | $7.72M | (m) | -16.26% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |